(Q51433901)

5 April 2018

title

Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium. (English)

1 reference

5 April 2018

author name string

T Nakai

1

1 reference

5 April 2018

K Satoh

2

1 reference

5 April 2018

T Kosugi

3

1 reference

5 April 2018

K Hoshi

4

1 reference

5 April 2018

K Ichihara

5

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

5 April 2018

European Journal of Pharmacology

published in

1 reference

5 April 2018

volume

382

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

187-196

1 reference

5 April 2018

Angiotensin receptors are implicated in the mechanism of mas action

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Angiotensin converting enzyme inhibitors and ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Difference between endocardial and epicardial utilization of glycogen in the ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Neuroendocrine changes in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Different distribution of two types of angiotensin II-generating enzymes in the aortic wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Converting-enzyme inhibition in the management of severe chronic congestive heart failure: physiologic concepts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Mechanism of coronary vasodilation produced by bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

Effects of BIBR-277, an angiotensin II type 1 receptor antagonist, on stunned myocardium in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900586-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00586-5

1 reference

5 April 2018

1 reference

5 April 2018